Mbx Biosciences, Inc. · NASDAQ:MBX
New Enterprise Associates 17, L.P. reported a 8.10% stake in Mbx Biosciences, Inc. (Schedule 13D/A)
Event Nov 6, 2025 · Filed Nov 10, 2025
New Enterprise Associates 17, L.P. reported a 8.10% stake in Mbx Biosciences, Inc., 3,614,486 shares, with active intent on Nov 6, 2025. Filed Nov 10, 2025 (Schedule 13D/A).
- Stake
- 8.10%
- Shares
- 3,614,486
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 12 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| New Enterprise Associates 17, L.P. | 8.10% | 3,614,486 |
| NEA Partners 17, L.P. | 8.10% | 3,614,486 |
| NEA 17 GP, LLC | 8.10% | 3,614,486 |
| Forest Baskett | 8.10% | 3,614,486 |
| Ali Behbahani | 8.10% | 3,614,486 |
| Carmen Chang | 8.10% | 3,614,486 |
| Anthony A. Florence, Jr. | 8.10% | 3,614,486 |
| Mohamad H. Makhzoumi | 8.10% | 3,614,486 |
| Edward T. Mathers | 8.10% | 3,619,474 |
| Scott D. Sandell | 8.10% | 3,614,486 |
| Paul Walker | 8.10% | 3,614,486 |
| Rick Yang | 8.10% | 3,614,486 |
Source
Related
- Mbx Biosciences, Inc.
- New Enterprise Associates 17, L.P.
- Mbx Biosciences, Inc. shareholders
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026
- Schedule 13D/A · James N. Topper · Aug 10, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Aug 10, 2026
- Form 4 · Azoulay Salomon · Aug 5, 2026
- Form 4 · Smither John W · Aug 4, 2026